NeOnc Signs MoU With Abu Dhabi Health Department to Advance Brain Cancer Research

• NeOnc Technologies signed a nonbinding memorandum of understanding with the Department of Health – Abu Dhabi to advance brain cancer research.
• The collaboration covers scientific exchange, specialist training and real-world evidence to strengthen CNS oncology research capabilities.
• The parties will assess clinical trial opportunities and a potential regional presence, including manufacturing, supply or distribution activities.
• Potential clinical studies and regional operations require separate agreements and regulatory approvals.
• A Phase 1 NEO100 study is being planned in Abu Dhabi, where two children already receive the investigational treatment through compassionate care.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Neonc Technologies Holdings Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610210800PRIMZONEFULLFEED9850365) on October 21, 2026, and is solely responsible for the information contained therein.